1
|
Aoun F, Kourie HR, Albisinni S, Roumeguère T. Will Testicular Germ Cell Tumors Remain Untargetable? Target Oncol 2017; 11:711-721. [PMID: 27184492 DOI: 10.1007/s11523-016-0439-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Testicular Germ cell tumors (TGCT) represent the most common solid tumors affecting young men. They constitute a distinct entity because of their embryonic origin and their unique biological behavior. Recently, new preclinical data on genetic and epigenetic susceptibility profiles, biological signaling machinery as well as on molecular patterns of tumors and pathways of pathogenesis helped to elucidate the pathogenesis and the differentiation of TGCTs and to understand the mechanisms behind the development of resistance to treatment. In the present work, we have reviewed new clues to the development, differentiation and progression of TGCTs. We focus on the most important epigenetic and molecular biomarkers, and discussed their diagnostic and prognostic accuracy compared to the currently used biomarkers. The mechanisms underlying the development of resistance to cisplatin and commonly used chemotherapeutic agents are also discussed in detail. Finally, we summarize failed and ongoing clinical trials using targeted therapies in resistant TGCTs, and analyze the potential of new targeted therapies.
Collapse
Affiliation(s)
- Fouad Aoun
- Department of Urology, Hôtel Dieu de France, Beyrouth, Lebanon.
| | - Hampig Raphael Kourie
- Department of Oncology, Jules Bordet Institute, 1 Héger Bordet Street, 1000, Brussels, Belgium
| | - Simone Albisinni
- Department of Urology, Erasme Hospital, Route de Lennik 808, 1070, Brussels, Belgium
| | - Thierry Roumeguère
- Department of Urology, Erasme Hospital, Route de Lennik 808, 1070, Brussels, Belgium
| |
Collapse
|
2
|
Hollowell JG. Undescended testis and infertility-Is hormonal therapy indicated? Transl Androl Urol 2014; 3:377-81. [PMID: 26814848 PMCID: PMC4708143 DOI: 10.3978/j.issn.2223-4683.2014.11.10] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2014] [Accepted: 11/10/2014] [Indexed: 11/25/2022] Open
Abstract
PURPOSE The purpose of this chapter is to review hormonal therapy in cryptorchidism in boys to improve fertility. METHODS Multiple searches, primarily in PubMed, were performed using various combinations of the terms: cryptorchidism, undescended testis (UDT), hormonal therapy, fertility, infertility, germ cell numbers, spermatogonia and semen analyses. In additions the pertinent articles from the reference lists in these papers were also obtained and reviewed. RESULTS Data on fertility in unilateral cryptorchidism does not reveal a significant risk for infertility. Testes biopsies in childhood do not correlate with fertility parameters in adulthood. In bilateral cryptorchidism there is a significant risk of infertility. Results of hormonal treatment were not reported separately for bilateral cryptorchidism. Current data is insufficient to know if hormonal therapy is efficacious in bilateral UDT. CONCLUSIONS Hormonal therapy should not be used in childhood to improve fertility in cases of unilateral cryptorchidism. Testes biopsies in childhood to identify those at risk for infertility should not be performed in unilateral cryptorchidism. More data are needed to answer whether hormonal therapy is beneficial in bilateral UDT. There is insufficient data to establish that testis biopsies are helpful in bilateral cryptorchidism in identifying the subgroup with risk for infertility. They should not be performed in the routine clinical setting but may have a role in a research protocol.
Collapse
Affiliation(s)
- Jean G Hollowell
- Albany Medical College, The Urological Institute of Northeastern, Albany, NY 12208, USA
| |
Collapse
|
3
|
Masini MA, Albi E, Barmo C, Bonfiglio T, Bruni L, Canesi L, Cataldi S, Curcio F, D'Amora M, Ferri I, Goto K, Kawano F, Lazzarini R, Loreti E, Nakai N, Ohira T, Ohira Y, Palmero S, Prato P, Ricci F, Scarabelli L, Shibaguchi T, Spelat R, Strollo F, Ambesi-Impiombato FS. The impact of long-term exposure to space environment on adult mammalian organisms: a study on mouse thyroid and testis. PLoS One 2012; 7:e35418. [PMID: 22558148 PMCID: PMC3338839 DOI: 10.1371/journal.pone.0035418] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2011] [Accepted: 03/15/2012] [Indexed: 12/30/2022] Open
Abstract
Hormonal changes in humans during spaceflight have been demonstrated but the underlying mechanisms are still unknown. To clarify this point thyroid and testis/epididymis, both regulated by anterior pituitary gland, have been analyzed on long-term space-exposed male C57BL/10 mice, either wild type or pleiotrophin transgenic, overexpressing osteoblast stimulating factor-1. Glands were submitted to morphological and functional analysis.In thyroids, volumetric ratios between thyrocytes and colloid were measured. cAMP production in 10(-7)M and 10(-8)M thyrotropin-treated samples was studied. Thyrotropin receptor and caveolin-1 were quantitized by immunoblotting and localized by immunofluorescence. In space-exposed animals, both basal and thyrotropin-stimulated cAMP production were always higher. Also, the structure of thyroid follicles appeared more organized, while thyrotropin receptor and caveolin-1 were overexpressed. Unlike the control samples, in the space samples thyrotropin receptor and caveolin-1 were both observed at the intracellular junctions, suggesting their interaction in specific cell membrane microdomains.In testes, immunofluorescent reaction for 3β- steroid dehydrogenase was performed and the relative expressions of hormone receptors and interleukin-1β were quantified by RT-PCR. Epididymal sperm number was counted. In space-exposed animals, the presence of 3β and 17β steroid dehydrogenase was reduced. Also, the expression of androgen and follicle stimulating hormone receptors increased while lutenizing hormone receptor levels were not affected. The interleukin 1 β expression was upregulated. The tubular architecture was altered and the sperm cell number was significantly reduced in spaceflight mouse epididymis (approx. -90% vs. laboratory and ground controls), indicating that the space environment may lead to degenerative changes in seminiferous tubules.Space-induced changes of structure and function of thyroid and testis/epididymis could be responsible for variations of hormone levels in human during space missions. More research, hopefully a reflight of MDS, would be needed to establish whether the space environment acts directly on the peripheral glands or induces changes in the hypotalamus-pituitary-glandular axis.
Collapse
Affiliation(s)
| | - Elisabetta Albi
- Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
| | | | | | - Lara Bruni
- DIPTERIS, University of Genoa, Genova, Italy
| | | | - Samuela Cataldi
- Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
| | - Francesco Curcio
- Department of Clinical and Biological Sciences, University of Udine, Udine, Italy
| | | | - Ivana Ferri
- Institute of Pathologic Anatomy and Histology, University of Perugia, Perugia, Italy
| | - Katsumasa Goto
- School of Health Sciences, Toyohashi SOZO University, Aichi, Japan
| | | | - Remo Lazzarini
- Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
| | - Elisabetta Loreti
- Institute of Pathologic Anatomy and Histology, University of Perugia, Perugia, Italy
| | - Naoya Nakai
- Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Takashi Ohira
- Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan
| | - Yoshinobu Ohira
- Graduate School of Medicine, Osaka University, Osaka, Japan
- Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan
| | | | - Paola Prato
- DIPTERIS, University of Genoa, Genova, Italy
| | | | | | | | - Renza Spelat
- Department of Clinical and Biological Sciences, University of Udine, Udine, Italy
| | | | | |
Collapse
|
4
|
Kokorowski PJ, Routh JC, Graham DA, Nelson CP. Variations in timing of surgery among boys who underwent orchidopexy for cryptorchidism. Pediatrics 2010; 126:e576-82. [PMID: 20732947 PMCID: PMC3102510 DOI: 10.1542/peds.2010-0747] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVE Current clinical guidelines recommend that orchidopexy be performed by the age of 1 in patients with congenital undescended testis. We sought to examine trends in surgical timing and to determine what factors are associated with age at surgery. METHODS The Pediatric Health Information System (PHIS) is a national database of >40 freestanding children's hospitals. We searched the PHIS to identify boys with cryptorchidism who underwent orchidopexy between 1999 and 2008. Patient age at orchidopexy was evaluated, and we used multivariate models to determine factors associated with timing of surgery. RESULTS We identified 28 204 children who underwent orchidopexy at PHIS hospitals. Of these, 14,916 (53%) were white, and 17,070 (61%) had public insurance. Only 5031 patients (18%) underwent orchidopexy by the age of 1 year; only 12,165 (43%) underwent orchidopexy by the age of 2 years. These figures remained stable over time (P=.32). After adjusting for patient clustering, race (P<.001) and insurance status (P<.001) remained associated with patient age at orchidopexy; however, the treating hospital (P<.001) was the most important factor in predicting the timing of the procedure. CONCLUSIONS Only 43% had surgery by 2 years of age, which suggests that either significant numbers of boys with congenital cryptorchidism do not undergo surgery in a timely fashion or late-onset testicular ectopy is more common than generally recognized. Factors associated with the timing of orchidopexy include patient race, insurance status, and the hospital in which surgery is performed.
Collapse
Affiliation(s)
| | - Jonathan C. Routh
- Department of Urology, Children’s Hospital Boston, Massachusetts,Harvard Pediatric Health Services Research Fellowship Program, Harvard Medical School, Boston, Massachusetts
| | - Dionne A. Graham
- Clinical Research Program, Children’s Hospital Boston, Massachusetts
| | - Caleb P. Nelson
- Department of Urology, Children’s Hospital Boston, Massachusetts
| |
Collapse
|
5
|
Abstract
Globally, testicular cancer incidence is highest among men of northern European ancestry and lowest among men of Asian and African descent. Incidence rates have been increasing around the world for at least 50 years, but mortality rates, at least in developed countries, have been declining. While reasons for the decreases in mortality are related to improvements in therapeutic regimens introduced in the late 1970s, reasons for the increase in incidence are less well understood. However, an accumulating body of evidence suggests that testicular cancer arises in fetal life. Perinatal factors, including exposure to endocrine-disrupting chemicals, have been suggested to be related to risk.
Collapse
Affiliation(s)
- Katherine A McGlynn
- Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20852-7234, USA.
| | | |
Collapse
|